Rate of early onset Alzheimer's disease: A systematic review and meta-analysis

Annals of Translational Medicine

Volumn 3, Issue 3, 2015, Pages

  Zhu, Xi Chen ^a   Tan, Lan ^a,b   Wang, Hui Fu ^a   Jiang, Teng ^a   Cao, Lei ^a   Wang, Chong ^b   Wang, Jun ^b   Tan, Chen Chen ^b   Meng, Xiang Fei ^b   Yu, Jin Tai ^a,b,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease (AD); Early onset Alzheimer's disease (EOAD); Meta analysis; Rate

Indexed keywords

EID: 85015464144     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.3978/j.issn.2305-5839.2015.01.19     Document Type: Article

References (41)

1. Rossor MN, Fox NC, Mummery CJ, et al. The diagnosis of young-onset dementia. Lancet Neurol 2010;9:793-806.
2. Jiang T, Yu JT, Tan L. Novel disease-modifying therapies for Alzheimer's disease. J Alzheimers Dis 2012;31:475-92.
3. Smits LL, Pijnenburg YA, Koedam EL, et al. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. J Alzheimers Dis 2012;30:101-8.
4. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010;362:329-44.
5. Jiang T, Yu JT, Tian Y, et al. Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors. Curr Alzheimer Res 2013;10:852-67.
6. Sassi C, Guerreiro R, Gibbs R, et al. Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease. Neurobiol Aging 2014;35:2422.e13-6.
7. Lopez OL, Swihart AA, Becker JT, et al. Reliability of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease. Neurology 1990;40:1517-22.
8. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-46.
9. Gomez R, Harvey J, Quick C, et al. DSM-IV AD/HD: confirmatory factor models, prevalence, and gender and age differences based on parent and teacher ratings of Australian primary school children. J Child Psychol Psychiatry 1999;40:265-74.
10. Miller JM, Pliskin NH. The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease. Int J Neurosci 2006;116:613-27.
11. Juva K, Sulkava R, Erkinjuntti T, et al. Usefulness of the Clinical Dementia Rating scale in screening for dementia. Int Psychogeriatr 1995;7:17-24.
12. ICD-9-CM. International Classification of Diseases, 9th revision, Clinical Modification. 3d edition, volumes 1, 2 and 3. Official authorized addendum effective October 1, 1990-HCFA. J Am Med Rec Assoc 1990;61:suppl 1-35.
13. Squitti R, Barbati G, Rossi L, et al. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology 2006;67:76-82.
14. Schoenberg BS, Anderson DW, Haerer AF. Severe dementia. Prevalence and clinical features in a biracial US population. Arch Neurol 1985;42:740-3.
15. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
16. Chandra V, Ganguli M, Pandav R, et al. Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study. Neurology 1998;51:1000-8.
17. Chandra V, Pandav R, Dodge HH, et al. Incidence of Alzheimer's disease in a rural community in India: the Indo-US study. Neurology 2001;57:985-9.
18. Suhanov AV, Pilipenko PI, Korczyn AD, et al. Risk factors for Alzheimer's disease in Russia: a case-control study. Eur J Neurol 2006;13:990-5.
19. Molero AE, Pino-Ramirez G, Maestre GE. High prevalence of dementia in a Caribbean population. Neuroepidemiology 2007;29:107-12.
20. Ott A, Breteler MM, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ 1995;310:970-3.
21. Ruitenberg A, Ott A, van Swieten JC, et al. Incidence of dementia: does gender make a difference? Neurobiol Aging 2001;22:575-80.
22. Schoenberg BS, Kokmen E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987;22:724-9.
23. Vas CJ, Pinto C, Panikker D, et al. Prevalence of dementia in an urban Indian population. Int Psychogeriatr 2001;13:439-50.
24. Coria F, Gomez de Caso JA, Minguez L, et al. Prevalence of age-associated memory impairment and dementia in a rural community. J Neurol Neurosurg Psychiatry 1993;56:973-6.
25. McGonigal G, Thomas B, McQuade C, et al. Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88. BMJ 1993;306:680-3.
26. Andreasen N, Blennow K, Sjodin C, et al. Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Pitea Dementia Project. Neuroepidemiology 1999;18:144-55.
27. Panegyres PK, Chen HY. Differences between early and late onset Alzheimer's disease. Am J Neurodegener Dis 2013;2:300-6.
28. Zhang ZX, Zahner GE, Roman GC, et al. Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol 2005;62:447-53.
29. Schoenberg BS, Anderson DW, Haerer AF. Severe dementia. Prevalence and clinical features in a biracial US population. Arch Neurol 1985;42:740-3.
30. Chandra V, Ganguli M, Pandav R, et al. Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study. Neurology 1998;51:1000-8.
31. Suhanov AV, Pilipenko PI, Korczyn AD, et al. Risk factors for Alzheimer's disease in Russia: a case-control study. Eur J Neurol 2006;13:990-5.
32. Molero AE, Pino-Ramirez G, Maestre GE. High prevalence of dementia in a Caribbean population. Neuroepidemiology 2007;29:107-12.
33. Ott A, Breteler MM, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ 1995;310:970-3.
34. Ruitenberg A, Ott A, van Swieten JC, et al. Incidence of dementia: does gender make a difference? Neurobiol Aging 2001;22:575-80.
35. Schoenberg BS, Kokmen E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987;22:724-9.
36. Vas CJ, Pinto C, Panikker D, et al. Prevalence of dementia in an urban Indian population. Int Psychogeriatr 2001;13:439-50.
37. Coria F, Gomez de Caso JA, Minguez L, et al. Prevalence of age-associated memory impairment and dementia in a rural community. J Neurol Neurosurg Psychiatry 1993;56:973-6.
38. McGonigal G, Thomas B, McQuade C, et al. Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88. BMJ 1993;306:680-3.
39. Andreasen N, Blennow K, Sjodin C, et al. Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Pitea Dementia Project. Neuroepidemiology 1999;18:144-55.
40. Panegyres PK, Chen HY. Differences between early and late onset Alzheimer's disease. Am J Neurodegener Dis 2013;2:300-6.
41. Zhang ZX, Zahner GE, Roman GC, et al. Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol 2005;62:447-53.